InvestorsHub Logo
icon url

Nemesis18

06/01/24 9:27 AM

#695358 RE: learningcurve2020 #695355

As a stagnated stand-alone treatment, DCVAX-L is 10-15 years too late. Neuroscience understanding has moved, so much so that GBM4 is not even recognised as a diagnosis any more by WHO.

NWBO owns a Nokia 3310, in a world of IPhone 14+

There will be NO NWBO buyout.
Advent almost certainly at a later date, as they produce combination variants for third parties , BUT for that, ADVENT does not need NWBO to get an MAA.
icon url

Nemesis18

06/01/24 9:35 AM

#695359 RE: learningcurve2020 #695355

>>Last year, the Government signed an agreement with BioNTech to provide up to 10,000 patients with precision cancer immunotherapies by 2030.

BioNTech has already begun conducting clinical trials in the UK, and the NHS launch pad is helping to accelerate the identification of eligible patients for those trials in England.



My God, don’t upset the faithful here with a reality-check !

#generationalwealth
icon url

drugrunner

06/01/24 2:27 PM

#695412 RE: learningcurve2020 #695355

Garbage in garbage out ..

If it’s posted by LC

just move on .. it’s a trash opinion